Rémy Cointreau SA reports organic net revenue growth below 5.0% for April–September 2026 in the H1-FY2027 sales report (approximately November 27, 2026, confirmed by Rémy Cointreau Investor Relations or Reuters by November 28, 2026)
Pending
✦ AI-generated prediction
Published on 30. September 2026
·
Predicted for 27. November 2026
·
Based on: Historical Cycle
Q1 FY2027 (April–June 2026) showed Rémy Cointreau with +1.3% organic growth on revenue of €223.2 million — a weak but positive recovery from the −8.7% collapse in H1 FY2026. The company reaffirmed full-year guidance of 'high single-digit' organic growth for FY2027, implying significant acceleration in Q2–Q4. For Q2 FY2027 (July–September 2026), key headwinds persist: (1) China — the primary cognac market — continues to suffer from subdued consumer confidence and MOFCOM anti-dumping tariffs on EU spirits (in force since October 2024); (2) US demand for premium cognac is moderating; (3) Rémy deliberately cut distillation capacity in 2023-25. The H1 growth rate is likely between Q1 (+1.3%) and the required H2 ramp-up — a figure above 5% for H1 would require a markedly strong Q2 (>+8%). Probability below 5%: approximately 62%. No Polymarket contract available.
Data basis for this prediction
- Rémy Cointreau Q1 FY2027 (April–Juni 2026): Umsatz 223,2 Mio. EUR, +1,3% organisch (Rémy Cointreau IR / Morningstar Business Wire, 29.07.2026)
- Rémy Cointreau H1 FY2026 Ergebnisse: −8,7% organisches Nettoumsatzwachstum (Rémy Cointreau IR, 27.11.2025)
- MOFCOM Anti-Dumping-Zölle auf EU-Branntwein/Cognac: in Kraft seit Oktober 2024 (Reuters, Oktober 2024)
- Rémy Cointreau FY2027-Guidance: 'high single-digit' organisches Wachstum (Rémy Cointreau Financial Calendar, remy-cointreau.com, 2026)
Verdict: Pending
This prediction is still open. It will be evaluated automatically against real-world sources after its due date.
🍾 Beverages
✦ AI
Diageo reported FY2026 (ended June 2026) organic net revenue growth of −2.0%, further deteriorating from −0.6% in FY2025. Structural headwinds are broad: North America (organic −5%, premium spirits downturn in whisky and tequila) and Asia Pacific (organic −4%, China normalization after COVID catch-up effects) dominate the picture. Q1 FY2027 (July–September 2026) faces the same macro backdrop: the Fed continues raising rates to 4.00–4.25% (open Cassandra prediction), dampening discretionary premium spending. Pernod Ricard is also predicted to report below 2% organic growth for the same period. A recovery to ≥2% in Q1 FY2027 appears unrealistic. No Polymarket/Kalshi equivalent.
🍾 Beverages
✦ AI
Pernod Ricard's FY2026 annual results (August 27, 2026) showed organic net revenue growth of −3%; US −14%, operating profit −17.9%, FCF €1.2bn. Structural headwinds persist for Q1 FY2027: weak Chinese consumer demand, US tariff exposure on Scotch whisky and Cognac, and a reversal in premiumisation trends. Competitor Diageo also reported −27.2% adjusted operating profit and −8.4% North America organic sales in FY2026. A recovery to >+2% organic growth in a single quarter would represent a significant inflection. No Polymarket market available; based on FY26 momentum and sector trends.
🍾 Beverages
✦ AI
Heineken H1 2026 showed strong growth — the share price rose following the half-year results (Investing.com earnings-call transcript, 2026). FY2026 company guidance: 2–6% organic operating profit growth (Q1 2026 Trading Update, April 23, 2026); organic net revenue growth has historically run above the operating-profit guidance range. A hot, dry summer 2026 across Europe and North Africa (Bordeaux 2026 harvest described as 'hottest in history', Wine-Searcher, September 2026), plus robust demand in growth markets (India, Nigeria, Vietnam), supports beer volumes. Q3 is historically Heineken's strongest trading period. No Polymarket level available; calibrated from company guidance and H1 signal.